To assess the clinical significance of MTA1/DNMT3a/IGFBP3 axis in breast cancer, we performed a two-way correlation involving low levels of DNMT3a and high levels of IGFBP3 associated with a poor distant metastasis-free survival (Fig. 7B). Here, DNMT3A is linked to breast cancer.